FDA, CDC Looking Into Reports Of Myocarditis After Moderna Shot
The Washington Post reports that an investigation is underway of emerging reports that the Moderna vaccine may carry a higher risk of the rare heart condition than the Pfizer vaccine, especially for males below the age of 30.
The Washington Post:
U.S. Officials Reviewing Possibility Moderna Vaccine Is Linked To Higher Risk Of Uncommon Side Effect Than Previously Thought
Federal health officials are investigating emerging reports that the Moderna coronavirus vaccine may be associated with a higher risk of a heart condition called myocarditis in younger adults than previously believed, according to two people familiar with the review who emphasized the side effect still probably remains uncommon. The investigation, which involves the Food and Drug Administration and the Centers for Disease Control and Prevention, is focusing on Canadian data that suggests the Moderna vaccine may carry a higher risk for young people than the Pfizer-BioNTech vaccine, especially for males below the age of 30 or so. The authorities also are scrutinizing data from the United States to try to determine whether there is evidence of an increased risk from Moderna in the U.S. population. (Pager and McGinley, 8/19)
Reuters:
U.S. Probing Moderna Vaccine For Higher Heart Inflammation Risk
U.S. health officials are investigating reports that Moderna Inc's COVID-19 vaccine may be linked to a higher risk of a rare heart condition in younger adults than previously thought, the Washington Post reported late on Thursday, citing people familiar with the review. The report quoted a source saying it was too early for the regulators to reach a conclusion, and that additional work was needed before any recommendation was made. (8/19)
